MedPath

Chlorhexidine

Generic Name
Chlorhexidine
Brand Names
Betasept, Hibiclens, Instillagel, Nupro Chlorhexidine, Oris, Oro-Clense, Paroex, Perichlor, Peridex, Periochip, Periogard, Prevora, X-pur
Drug Type
Small Molecule
Chemical Formula
C22H30Cl2N10
CAS Number
55-56-1
Unique Ingredient Identifier
R4KO0DY52L
Background

Chlorhexidine is a broad-spectrum antimicrobial biguanide used as a topical antiseptic and in dental practice for the treatment of inflammatory dental conditions caused by microorganisms. It is one of the most common skin and mucous membrane antiseptic agents in use today. The molecule itself is a cationic bis-guanide consisting of two 4-chlorophenyl rings and two biguanide groups joined by a central hexamethylene chain. Topical chlorhexidine for disinfection, as well as oral rinses for dental use, carries activity against a broad range of pathogens including bacteria, yeasts, and viruses.

Chlorhexidine was developed in the UK by Imperial Chemical Industries in the early 1950s and was introduced to the US in the 1970s. The FDA withdrew its approval for the use of chlorhexidine gluconate topical tincture 0.5%, due to a significant number of reports concerning chemical and thermal burns associated with the use of this product. Other formulations of chlorhexidine continue to be available.

Indication

Chlorhexidine is available over-the-counter in various formulations (e.g. solution, sponge, cloth, swab) as a topical antiseptic to sanitize prior to surgeries and/or medical procedures. Dental formulations, available by prescription only, include an oral rinse indicated for the treatment of gingivitis and a slow-release "chip" which is inserted into periodontal pockets and is indicated for the reduction of pocket depth in adult patients with periodontitis as an adjunct therapy to dental scaling and root planing procedures.

Associated Conditions
Aphthous ulcer, Catarrh of the throat, Chemotherapy Induced Oral Mucositis, Chronic Wounds, Decubitus Ulcer, Dental Cavity, Dysphagia, Eczema infected, Foeter Ex Ore, Gingival Bleeding, Gingival Diseases, Gingivitis, Glossitis, Hoarseness, Infection, Infectious Periodontal Diseases, Injury Throat, Mild to Moderate Inflammatory Reaction of the Oral Cavity, Mild to Moderate Inflammatory Reaction of the Pharynx, Mouth injury, Mucositis, Neurodermatitis, Ocular Inflammation, Ocular Irritation, Oral Aphthous Ulcer, Pain, Periodontitis, Pharyngitis, Plaque, Dental, Postoperative Wound Infection, Purulent Gingivitis, Radiation Mucositis, Red eye, Ringworm, Skin Infections, Sore Throat, Stomatitis, Surgical Wounds, Tissue Damage, Tonsillitis, Ulcers, Leg, Wound Infections, Bacterial skin infections, Dry, cracked skin, Gum pain, Moderate Gingivitis, Oral infections, Oral lesions, Recurrent Oral fungal infection, Severe Gingivitis, Superficial Wounds, Throat disinfection, Tongue inflammation
Associated Therapies
Anesthesia of Mucous Membrane, Antimicrobial Therapy, Contact Lens Care, Disinfection, Disinfection of External Genitalia, Disinfection of the Urethra, Disinfection of the Vaginal Mucosa, Irrigation therapy, Lubrication of the Urethra, Oral Care, Oral Hygiene, Oropharyngeal antisepsis, Promotion of wound healing, Skin disinfection, Surgical Scrubbing, Topical Antisepsis, Urethral Anesthesia, Wound Cleansing, Oral antisepsis, Oral disinfection

Oropharyngeal and Nasopharyngeal Decontamination With Chlorhexidine Gluconate in the Reduction of the Postoperative Morbidity and Mortality After Major Pulmonary Resections

Phase 3
Completed
Conditions
Infections and Respiratory Infectious
Interventions
First Posted Date
2012-06-07
Last Posted Date
2015-08-07
Lead Sponsor
Assistance Publique Hopitaux De Marseille
Target Recruit Count
474
Registration Number
NCT01613365
Locations
🇫🇷

Assistance Publique Hopitaux de Marseille, Marseille, France

Efficacy of Two Commercially Available Chlorhexidine Mouthrinses Non-alcohol Base

Phase 1
Completed
Conditions
Dental Plaque
Interventions
First Posted Date
2012-04-19
Last Posted Date
2012-04-24
Lead Sponsor
Universidade do Porto
Target Recruit Count
50
Registration Number
NCT01580943
Locations
🇵🇹

Faculdade de Medicina Dentária da Universidade do Porto, Porto, Portugal

Evaluation of a Staphylococcus Eradication Protocol for Patients Who Present to the ED With Cutaneous Abscess

Phase 4
Completed
Conditions
Cutaneous Abscess
Interventions
First Posted Date
2012-02-23
Last Posted Date
2017-04-13
Lead Sponsor
Tufts Medical Center
Target Recruit Count
50
Registration Number
NCT01537783
Locations
🇺🇸

Tufts Medical Center, Boston, Massachusetts, United States

Study of Chlorhexidine Gluconate as a Preoperative Antisepsis

Phase 3
Completed
Conditions
Surgical Site Infection
Interventions
First Posted Date
2011-12-19
Last Posted Date
2016-12-21
Lead Sponsor
Seung Duk Lee
Target Recruit Count
534
Registration Number
NCT01495117
Locations
🇰🇷

National Cancer Center, Republic of Korea, Goyang-si, Gyeonggi-do, Korea, Republic of

Chlorhexidine Gluconate Oral Care for Adults Experiencing Trauma

Not Applicable
Completed
Conditions
Ventilator Associated Pneumonia
Interventions
First Posted Date
2011-06-27
Last Posted Date
2017-02-06
Lead Sponsor
St. Joseph's Hospital and Medical Center, Phoenix
Target Recruit Count
66
Registration Number
NCT01382446
Locations
🇺🇸

St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States

Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)

Phase 2
Terminated
Conditions
Cystic Fibrosis
Methicillin-resistant Staphylococcus Aureus
Interventions
First Posted Date
2011-05-06
Last Posted Date
2017-05-15
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
47
Registration Number
NCT01349192
Locations
🇺🇸

St. Louis Children's Hospital, St. Louis, Missouri, United States

🇺🇸

University of Texas Southwestern Medical Center, Dallas, Texas, United States

🇺🇸

The Children's Hospital, Aurora, Colorado, United States

and more 10 locations

A Cluster-randomized Cross-over Trial Evaluating the Comparative Effectiveness of Three Skin Antiseptic Interventions

Not Applicable
Completed
Conditions
Bacteremia
Interventions
First Posted Date
2010-10-07
Last Posted Date
2017-01-11
Lead Sponsor
University of Michigan
Target Recruit Count
3879
Registration Number
NCT01216761

Effects Of Chlorhexidine Mouthrinse On Peridontopathogens: A Randomized, Placebo-Controlled Study

Phase 4
Completed
Conditions
This Study Evaluated the Effectiveness of Chlorhexidine Mouthrinse on Subgingival Microbiota
Interventions
Drug: Placebo mouthrinse
Drug: Chlorhexidine gluconate
First Posted Date
2010-10-04
Last Posted Date
2010-10-04
Lead Sponsor
Ege University
Target Recruit Count
50
Registration Number
NCT01213550
Locations
🇹🇷

Ege U School of Dentistry, Izmir, Bornova, Turkey

🇹🇷

Ege University School of Dentistry Dep of Periodontology, Izmir, Bornova, Turkey

Hexetidine and Chlorobutanol for Lesions Due to Prostheses

Phase 4
Completed
Conditions
Oral Mucositis
Interventions
First Posted Date
2010-05-03
Last Posted Date
2010-05-03
Lead Sponsor
Federico II University
Target Recruit Count
44
Registration Number
NCT01115049
Locations
🇮🇹

University "Federico II", Department of Prosthodontics, Naples, Italy

Methicillin-resistant Staphylococcus Aureus (MRSA) Skin and Soft Tissue Infection (SSTI) Prevention in Military Trainees

Not Applicable
Completed
Conditions
Staphylococcus Aureus
MRSA Skin Infections
Staphylococcal Skin Infections
Interventions
Other: Supplemental training, education and hygiene
Drug: Chlorhexidine gluconate
First Posted Date
2010-04-16
Last Posted Date
2023-02-03
Lead Sponsor
Henry M. Jackson Foundation for the Advancement of Military Medicine
Target Recruit Count
30209
Registration Number
NCT01105767
Locations
🇺🇸

Usa Meddac Mach, Columbus, Georgia, United States

© Copyright 2025. All Rights Reserved by MedPath